Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.22.2
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-based Compensation Expense

Stock-based compensation expense is as follows:

 

 

 

For the Year Ended

 

 

 

December 31

 

 

 

2021

 

 

2020

 

Research and development

 

$

159

 

 

$

252

 

Sales and marketing

 

 

188

 

 

 

230

 

General and administrative

 

 

673

 

 

 

548

 

Cost of revenues

 

 

65

 

 

 

57

 

 

 

$

1,085

 

 

$

1,087

 

Summary of Stock Option Activity

Stock option activity for the years ended December 31, 2021 and 2020 is as follows and reflects the 1-for-10 Reverse Stock Split that became effective on September 15, 2021:

 

 

 

 

 

 

 

Weighted average

exercise price

 

 

Weighted average

remaining

contractual life

 

 

Aggregate

Intrinsic

 

 

 

Options

 

 

per share

 

 

(in years)

 

 

Value*

 

Outstanding at January 1, 2020

 

 

264,443

 

 

$

35.00

 

 

 

8.51

 

 

$

4,184

 

Options granted

 

 

2,600

 

 

$

8.58

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(54,116

)

 

$

7.06

 

 

 

 

 

 

 

 

 

Options forfeited

 

 

(51,079

)

 

$

47.27

 

 

 

 

 

 

 

 

 

Options cancelled

 

 

(17,545

)

 

$

70.44

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

144,303

 

 

$

36.37

 

 

 

7.82

 

 

$

24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

0

 

 

$

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(707

)

 

$

7.50

 

 

 

 

 

 

 

 

 

Options forfeited

 

 

(23,171

)

 

$

27.55

 

 

 

 

 

 

 

 

 

Options cancelled

 

 

(25,012

)

 

$

29.60

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

95,413

 

 

$

40.00

 

 

 

6.73

 

 

$

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2021

 

 

95,413

 

 

$

40.00

 

 

 

6.71

 

 

$

0

 

Exercisable at December 31, 2021

 

 

61,130

 

 

$

44.34

 

 

 

6.05

 

 

$

0

 

 

*The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.

Summary of Fair Value of Option Grants Valuation Assumptions

The fair value of option grants made during the years ended December 31, 2020, was estimated using the following Black-Scholes option pricing model assumptions:

 

 

 

2020

 

 

 

 

Expected dividend yield

 

 

0%

 

 

 

 

 

Risk-free interest rate

 

0.26%-0.46%

 

 

 

 

Expected volatility

 

 

50%

 

 

 

 

 

Expected life (in years)

 

 

6.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Outstanding RSU's

The following table summarized the outstanding RSU’s as of December 31, 2021:

 

 

 

RSU's

 

Outstanding at January 1, 2021

 

 

269,138

 

Granted

 

 

220,268

 

Released

 

 

(55,683

)

Forfeited

 

 

(86,612

)

Outstanding at December 31, 2021

 

 

347,111